newsfilter
← Latest News
ClinicalTrials.gov·

MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients - NCT04646603

Phase Ib, Phase IIa, Change in percentages from baseline in circulating white blood cell subpopulations, (and 19 more...)